JERSEY CITY, NJ - August 9, 2024 - Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced a managed services agreement with TELUS, a world-leading communications technology company to move their existing on-premise monetization operations to Amazon Web Services (AWS).
By migrating these operations to AWS’ state-of-the art cloud infrastructure, TELUS will benefit from enhanced flexibility, reliability and scalability so it can bring new products to market faster, at reduced costs, while elevating the customer experience.
"As a global technology powerhouse accelerating our digital transformation, our move to the cloud continues to be a critical priority for TELUS – unlocking new opportunities in both consumer and enterprise markets," said Hesham Fahmy, Chief Information Officer, TELUS. "We're excited to expand our collaboration with Amdocs as we continue to deliver world-leading technology solutions and faster, more personalized customer outcomes."
"We are pleased to collaborate with Amazon Web Services to migrate our customers' mission-critical monetization systems to the cloud," said Anthony Goonetilleke, Group President of Technology and Head of Strategy, Amdocs. "By migrating core systems to the cloud, TELUS will be well-positioned to delight their customers, by leveraging benefits of the public cloud to deliver amazing customer experiences."
Supporting Resources
- Read more about Services
- Keep up with Amdocs news by visiting the company’s website
- Follow us on X, Facebook, LinkedIn and YouTube
About Amdocs
Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers’ innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and enterprise customers. Our approximately 29,000 employees around the globe are here to accelerate service providers’ migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $4.89 billion in fiscal 2023. For more information, visit www.amdocs.com
Amdocs’ Forward-Looking Statement
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macro-economic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events and the COVID-19 pandemic, as well as the current inflationary environment, and the effects of these conditions on the company’s customers’ businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the company’s customers, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the company’s offerings and operations and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2023 filed on December 13, 2023 and our Form 6-K furnished for the first quarter of fiscal 2024 on February 20, 2024, and for the second quarter of fiscal 2024 on May 20, 2024.